Last reviewed · How we verify
NCT03617627
Self-management Program in Chronic Pelvic Pain
NA trial testing Self-management intervention in Chronic Pelvic Pain in 44 participants. Completed in 29 April 2019.
21 October 2018
Quick facts
| Lead sponsor | Universidad de Granada |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 44 |
| Start date | 23 July 2018 |
| Primary completion | 21 October 2018 |
| Estimated completion | 29 April 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Self-management intervention
Conditions studied
- Chronic Pelvic Pain — all drugs for Chronic Pelvic Pain →
Sponsor
Universidad de Granada — full company profile →
Who can join
18 and older, female only, with Chronic Pelvic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chronic pelvic pain is a serious health condition with an estimated prevalence of 15% women worldwide.Treatment is a challenge given the different pain generators described. It is important to develop self-management interventions to reduce the frustration associated with its management.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03617627
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Self-management intervention
Trials testing the same drug.
- NCT06932406 — Orofacial Pain Self-management: Personality Moderation Effect · NA · recruiting
- NCT05553444 — Effect of Self-management Intervention on Pain Intensity and Functional Disability in Adolescent Patients With Low Back · NA · completed
Other recruiting trials for Chronic Pelvic Pain
Currently open trials in the same condition.
- NCT06995287 — Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysme · Phase 3 · recruiting
- NCT06778070 — National Program to Overcome Pelvic Pain studY (POPPY) · NA · recruiting
- NCT06413277 — Targeting the Conus Medullaris With ECAP-Controlled Closed-Loop SCS for Treatment of Chronic Pelvic Pain: HOPE Trial · recruiting
- NCT07494864 — Effects of Microbiological and Immunological Factors on the Lower Urinary Tract · recruiting
- NCT06908200 — Effect of Radiofrequency in Women With Chronic Pelvic Pain With an Associated Myofascial Syndrome Versus Myofascial Ther · NA · recruiting
Other Universidad de Granada trials
Trials by the same sponsor.
- NCT07497698 — Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults · NA · recruiting
- NCT07528924 — TuJugling: Comparing Two Juggling Learning Methods in College Students · NA · recruiting
- NCT07388134 — Virtual Reality Based High-intensity Interval Training in Chronic Low Back Pain · NA · active not recruiting
- NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
- NCT06518200 — Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03617627 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de Granada
- Last refreshed: 4 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03617627.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing